Study of rare HIV types in Cameroon
Part of Immune system & allergy, Infections clinical trials.
This study looks at rare types of HIV (not the common group M) using stored blood samples from people in Cameroon. It may help researchers understand these rare virus types better, but participation is limited to specific locations and time periods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an HIV test in Cameroon as part of a national health survey in 2011 or 2018, or you had an HIV test or viral load check at Centre Pasteur in Yaoundé or Garoua.
- You are at least 21 years old.
- Your HIV is not the common group M type — this study looks at rarer forms.
- You have a stored blood sample (dried blood spot) that is in good condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
This study looks at how certain immune cells (NK cells) behave in people who have been on HIV treatment for a long time. It aims to understand why some people's immune systems respond differently, which could help improve future treatments.
This trial collects blood samples from people living with HIV to study dormant (inactive) HIV cells in the lab. The goal is to better understand how to target these hidden cells as part of an eventual cure.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.